Developer docs
API playgroundTry for free, no card

Search company profiles

Symbiont

Full company profile

uuid00027j6

Namestring
Symbiont
Websiteurl
symbiont.io
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Symbiont is a New York-based, private for-profit company founded in 2013 that has built a market-leading enterprise platform for institutional applications of blockchain technology. The company targets financial-market participants — evidenced by a dedicated securitization business-development function and a transaction-processing product line — and operates with a headcount of 51 to 100 employees. Its platform enables institutional-grade distributed-ledger deployments for capital-markets workflows, positioning it within the enterprise DLT segment rather than the consumer or crypto-asset trading segments.

The company's capital structure reflects deep institutional validation. Across eight disclosed funding events from 2014 through 2021, Symbiont raised cumulative disclosed funding of approximately $36.6 million, with strategic participation from Nasdaq Ventures, Citi Ventures, Galaxy Digital, and Hearst's Financial Venture Fund. The 2019 $20 million round — the company's largest — was led by Nasdaq Ventures, anchoring a syndicate that included multiple capital-markets-aligned investors, and the 2017 round brought in Asian financial-technology investors (Fenbushi Capital, Hundsun Technologies), indicating an early cross-border distribution posture.

The senior leadership team combines capital-markets product expertise with blockchain engineering, including a co-founder/COO (Evan Wagner), a Chief Marketing & Communications Officer, a Chief People Officer, a VP of Business Development for Securitization, and a lead software engineer. Revenue mechanics are not publicly disclosed and the pricing model is not detailed in the available data, but the customer profile (institutional financial firms), deal complexity, and investor composition are consistent with an enterprise SaaS or platform-license model with high contract values and long sales cycles.

Short descriptiontext

Symbiont is a New York-based enterprise blockchain software company founded in 2013 that builds a distributed-ledger platform for institutional financial-market use cases, including securitization and transaction processing, serving large financial institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
enterprise blockchain platform, institutional distributed ledger, blockchain securitization, smart contract infrastructure, financial market blockchain
Industry2 codes
1Permissioned Blockchain Platforms & Frameworks (Hyperledger, Corda, Quorum)
CodeFSAPAIAAPrimaryYes
2Tokenized Securities & Capital Markets Infrastructure (equities, bonds, funds, ATS/MTF connectivity)
CodeFSAPAIADPrimaryNo
NAICS code2 codes
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
  • Financial Transactions Processing, Reserve, and Clearinghouse Activities522320
SIC code2 codes
  • Services-Prepackaged Software7372
  • Finance Services6199
Product category
Enterprise Blockchain Platform
Social media profiles2 records
Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Symbiont has developed a market-leading enterprise blockchain platform designed for institutional applications of distributed ledger technology. The platform supports transaction processing and securitization use cases for financial market participants, providing regulated institutions with immutable record-keeping and smart contract execution. It is positioned for deployment within banks, asset managers, exchanges, and other capital markets intermediaries.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Symbiont Enterprise Blockchain Platform
CategoryEnterprise Blockchain Platform
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Ava Labs, developer of Avalanche, has built the Evergreen subnet architecture that supports permissioned institutional chains for finance and asset tokenization. It competes with Symbiont by offering a more developer-friendly public/hybrid alternative for institutional use cases.

TypeBroad incumbent
Description

Hyperledger is the leading open-source collaborative effort for enterprise blockchain frameworks including Fabric, Besu, and Sawtooth. As a broad incumbent, it provides an alternative open-source infrastructure path for the same institutional customers Symbiont serves.

TypeEmerging player
Description

tZERO is a Medici Ventures-backed platform providing blockchain infrastructure for tokenized securities issuance and trading. It overlaps with Symbiont in tokenized capital markets infrastructure and shares an investor lineage through Medici Ventures.

TypeBroad incumbent
Description

Polygon offers Polygon Supernets, a customizable blockchain infrastructure enabling permissioned chains for enterprises including financial institutions. As a broader incumbent with extensive tooling and ecosystem, it provides an alternative path for institutions adopting blockchain for capital markets.

TypeDirect peer
Description

Securitize is a leading digital asset securities platform for issuance, compliance, and secondary trading of tokenized securities. It overlaps directly with Symbiont's securitization and tokenized capital markets focus, though Securitize is more application-layer while Symbiont provides the underlying blockchain infrastructure.

TypeDirect peer
Description

Consensys is a leading Ethereum-focused enterprise blockchain company providing infrastructure including Hyperledger Besu/Quorum. It competes with Symbiont in the institutional permissioned blockchain space, particularly for capital markets and financial services applications.

TypeEmerging player
Description

Kadena is an enterprise-focused blockchain combining a public chain with a permissioned variant (Kuro) for institutions. It competes with Symbiont in financial services use cases with a hybrid public/permissioned architecture targeting similar institutional customers.

TypeEmerging player
Description

Provenance Blockchain is a permissioned chain purpose-built for financial services, particularly asset management, private credit, and securitization. It directly overlaps with Symbiont's institutional finance focus on private funds and structured products.

9R3
TypeDirect peer
Description

R3 builds Corda, the leading enterprise-grade permissioned DLT platform for financial services with 300+ institutional members. Symbiont is directly comparable as a permissioned blockchain platform targeting institutional finance customers, with overlapping product positioning and customer base.

TypeDirect peer
Description

Digital Asset builds the Daml smart contract language and enterprise blockchain infrastructure for capital markets. It is a direct competitor to Symbiont in institutional blockchain applications with a similar enterprise customer profile and capital markets focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors20 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Symbiont

Enterprise Blockchain Platformsymbiont.io

Symbiont is a New York-based enterprise blockchain software company founded in 2013 that builds a distributed-ledger platform for institutional financial-market use cases, including securitization and transaction processing, serving large financial institutions.

What Symbiont does

Symbiont is a New York-based, private for-profit company founded in 2013 that has built a market-leading enterprise platform for institutional applications of blockchain technology. The company targets financial-market participants — evidenced by a dedicated securitization business-development function and a transaction-processing product line — and operates with a headcount of 51 to 100 employees. Its platform enables institutional-grade distributed-ledger deployments for capital-markets workflows, positioning it within the enterprise DLT segment rather than the consumer or crypto-asset trading segments.

The company's capital structure reflects deep institutional validation. Across eight disclosed funding events from 2014 through 2021, Symbiont raised cumulative disclosed funding of approximately $36.6 million, with strategic participation from Nasdaq Ventures, Citi Ventures, Galaxy Digital, and Hearst's Financial Venture Fund. The 2019 $20 million round — the company's largest — was led by Nasdaq Ventures, anchoring a syndicate that included multiple capital-markets-aligned investors, and the 2017 round brought in Asian financial-technology investors (Fenbushi Capital, Hundsun Technologies), indicating an early cross-border distribution posture.

The senior leadership team combines capital-markets product expertise with blockchain engineering, including a co-founder/COO (Evan Wagner), a Chief Marketing & Communications Officer, a Chief People Officer, a VP of Business Development for Securitization, and a lead software engineer. Revenue mechanics are not publicly disclosed and the pricing model is not detailed in the available data, but the customer profile (institutional financial firms), deal complexity, and investor composition are consistent with an enterprise SaaS or platform-license model with high contract values and long sales cycles.

Symbiont firmographics

Firmographics
Name
Symbiont
Website
https://symbiont.io
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
51–100 employees
Short description
Symbiont is a New York-based enterprise blockchain software company founded in 2013 that builds a distributed-ledger platform for institutional financial-market use cases, including securitization and transaction processing, serving large financial institutions.
Ownership category
akta.pro rank

Symbiont industry classification

Industry
Product category
Enterprise Blockchain Platform
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Financial Transactions Processing, Reserve, and Clearinghouse Activities (522320)
SIC
Services-Prepackaged Software (7372), Finance Services (6199)
akta.pro primary industry
Permissioned Blockchain Platforms & Frameworks (Hyperledger, Corda, Quorum) (FSAPAIAA)
akta.pro secondary industry
Tokenized Securities & Capital Markets Infrastructure (equities, bonds, funds, ATS/MTF connectivity) (FSAPAIAD)

Keywords

  • Enterprise blockchain platform
  • Institutional distributed ledger
  • Blockchain securitization
  • Smart contract infrastructure
  • Financial market blockchain

Where Symbiont is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Markets served

Symbiont business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Symbiont product offering

Product offering

Core offering

Symbiont has developed a market-leading enterprise blockchain platform designed for institutional applications of distributed ledger technology. The platform supports transaction processing and securitization use cases for financial market participants, providing regulated institutions with immutable record-keeping and smart contract execution. It is positioned for deployment within banks, asset managers, exchanges, and other capital markets intermediaries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Symbiont Enterprise Blockchain Platform

Companies that use Symbiont

Customer profile

Ideal customer profiles1 record

Symbiont technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Symbiont partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Symbiont competitors and assessment

Company assessment

Emerging players

  • Ava Labs (Avalanche): Ava Labs, developer of Avalanche, has built the Evergreen subnet architecture that supports permissioned institutional chains for finance and asset tokenization. It competes with Symbiont by offering a more developer-friendly public/hybrid alternative for institutional use cases.
  • tZERO: tZERO is a Medici Ventures-backed platform providing blockchain infrastructure for tokenized securities issuance and trading. It overlaps with Symbiont in tokenized capital markets infrastructure and shares an investor lineage through Medici Ventures.
  • Kadena: Kadena is an enterprise-focused blockchain combining a public chain with a permissioned variant (Kuro) for institutions. It competes with Symbiont in financial services use cases with a hybrid public/permissioned architecture targeting similar institutional customers.
  • Provenance Blockchain: Provenance Blockchain is a permissioned chain purpose-built for financial services, particularly asset management, private credit, and securitization. It directly overlaps with Symbiont's institutional finance focus on private funds and structured products.

Broad incumbents

  • Hyperledger (Linux Foundation): Hyperledger is the leading open-source collaborative effort for enterprise blockchain frameworks including Fabric, Besu, and Sawtooth. As a broad incumbent, it provides an alternative open-source infrastructure path for the same institutional customers Symbiont serves.
  • Polygon Labs: Polygon offers Polygon Supernets, a customizable blockchain infrastructure enabling permissioned chains for enterprises including financial institutions. As a broader incumbent with extensive tooling and ecosystem, it provides an alternative path for institutions adopting blockchain for capital markets.

Direct peers

  • Securitize: Securitize is a leading digital asset securities platform for issuance, compliance, and secondary trading of tokenized securities. It overlaps directly with Symbiont's securitization and tokenized capital markets focus, though Securitize is more application-layer while Symbiont provides the underlying blockchain infrastructure.
  • Consensys: Consensys is a leading Ethereum-focused enterprise blockchain company providing infrastructure including Hyperledger Besu/Quorum. It competes with Symbiont in the institutional permissioned blockchain space, particularly for capital markets and financial services applications.
  • R3: R3 builds Corda, the leading enterprise-grade permissioned DLT platform for financial services with 300+ institutional members. Symbiont is directly comparable as a permissioned blockchain platform targeting institutional finance customers, with overlapping product positioning and customer base.
  • Digital Asset Holdings: Digital Asset builds the Daml smart contract language and enterprise blockchain infrastructure for capital markets. It is a direct competitor to Symbiont in institutional blockchain applications with a similar enterprise customer profile and capital markets focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

Symbiont social profiles

Digital presence

Symbiont financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Symbiont leadership team

Management profile

Number of profiles

Profiles6 records

Symbiont funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors20 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Symbiont M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Symbiont

What does Symbiont do?

Symbiont has developed a market-leading enterprise blockchain platform designed for institutional applications of distributed ledger technology. The platform supports transaction processing and securitization use cases for financial market participants, providing regulated institutions with immutable record-keeping and smart contract execution. It is positioned for deployment within banks, asset managers, exchanges, and other capital markets intermediaries.

When was Symbiont founded?

Symbiont was founded in 2013. It employs 51 to 100 people.

Where is Symbiont based?

Symbiont is headquartered in New York, United States, in the North America region.

Who are Symbiont's main competitors?

Emerging players on record are Ava Labs (Avalanche), tZERO, Kadena and Provenance Blockchain. Broad incumbents are Hyperledger (Linux Foundation) and Polygon Labs. Direct peers are Securitize, Consensys, R3 and Digital Asset Holdings.

Does Symbiont have an API?

No public API is recorded for Symbiont.

What industry is Symbiont in?

Symbiont's product category is Enterprise Blockchain Platform. Its primary akta.pro industry code is FSAPAIAA, Permissioned Blockchain Platforms & Frameworks (Hyperledger, Corda, Quorum), with a secondary code of FSAPAIAD, Tokenized Securities & Capital Markets Infrastructure (equities, bonds, funds, ATS/MTF connectivity). Its NAICS code is 518 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireLM Funding Sells Symbiont's Blockchain Technology to Platonic Holdings Inc.LM Funding signed an agreement to sell Symbiont's blockchain technology to Platonic Holdings for $2 million, with $200,000 held in escrow until December 26, 2024. The company acquired the assets in its Chapter 11 case and recorded them at $2 million. The funds will support bitcoin mining growth and working capital ahead of the 2024 halving.GlobeNewswireLM Funding Sells Symbiont's Blockchain Technology to Platonic Holdings Inc.LM Funding signed an agreement to sell Symbiont's blockchain technology to Platonic Holdings for $2 million, with $200,000 held in escrow until December 26, 2024. The company acquired the assets in its Chapter 11 case and recorded them at $2 million. The funds will support bitcoin mining growth and working capital ahead of the 2024 halving.PR NewswireLM Funding America, Inc. Announces Stalking Horse Bid to Purchase the Assets of Symbiont.io, Inc. Out of Chapter 11 BankruptcyLM Funding America, Inc. announced a $2.6 million stalking horse bid to purchase the assets of Symbiont.io, Inc., which filed for Chapter 11 bankruptcy protection on December 1, 2022, with the bid expected to be approved by the bankruptcy court and an auction for competing bids scheduled for May 26, 2023. LM Funding currently holds the position of sole secured creditor for Symbiont as a result of a $2 million secured loan made in December 2021. If the acquisition is successful, LM Funding intends to pursue joint ventures and strategic relationships to offer Symbiont's Assembly blockchain platform to financial institutions for issuing, tracking, and managing financial instruments.Ledger InsightsBankruptcies of blockchain firms Marco Polo, Symbiont attract biddersBlockchain firms Marco Polo and Symbiont, both still operating, entered insolvency and Chapter 11 respectively, with potential buyers exploring acquisition of their assets. Marco Polo's insolvency followed a failed $12 million investment from Bank of America, while Symbiont faces liquidations after a failed rescue attempt. Both companies had high-profile clients and backers, including major banks.BenzingaEXCLUSIVE: Crypto Contagion Infects Fintech — But It's Apples And Oranges, Symbiont CEO SaysAt the 2022 Benzinga Global Fintech Deal Day event, Symbiont CEO Mark Smith and other blockchain professionals from Northern Trust, U.S. Bank, and Deloitte discussed how scrutiny from crypto failures like Luna and FTX unfairly affects traditional fintech companies, arguing the technologies are fundamentally different. Panelists advised financial services firms to gain top-level organizational support, clearly understand the problems they aim to solve with blockchain, and engage regulators early in implementation projects. The discussion emphasized that many failed blockchain projects resulted from inappropriate application of the technology rather than flaws in blockchain itself.Forbes IndiaSWIFT and Symbiont announce new pilot projectSWIFT announced a pilot project with FinTech firm Symbiont on September 13, using Symbiont's blockchain platform and smart contracts to automate and improve accuracy of corporate action workflows. The trial involves seven securities players, including American Century Investments, Citi, Vanguard and Northern Trust, and aims to distribute data in near real-time to global custody clients.PR NewswireSymbiont Announces Appointment of Ann Neidenbach to Board of DirectorsSymbiont, a fintech company specializing in enterprise blockchain solutions, appointed Ann Neidenbach to its Board of Directors on July 27, 2022. Neidenbach brings over three decades of technology leadership experience at global financial services organizations including LSEG, Cowen, BNY Convergex, Nasdaq, and Citi. She succeeds Todd Ruppert, who stepped down from the Board concurrently.PR NewswireSymbiont Announces Expansion of Executive Leadership Team Naming New Chief Marketing Officer & Chief People OfficerSymbiont, Inc. announced the expansion of its executive leadership team with the appointment of Silvia Davi as Chief Marketing and Communications Officer and Tom DeJarnette as Chief People Officer, both newly created positions reporting to CEO Mark Smith, effective at the end of Q4 2021. Both executives bring extensive experience in financial services, technology, and organizational leadership, with Davi having previously held roles at Nasdaq, Instinet, and various fintech companies, and DeJarnette bringing military leadership experience as a retired Navy SEAL. The company noted 2021 milestones including its smart collateral application going live with Vanguard and State Street as evidence of its growth trajectory.GlobeNewswireMedici Ventures Keiretsu Companies GrainChain and Symbiont Working Together to Expand Global OperationsMedici Ventures announced that GrainChain and Symbiont are collaborating to expand GrainChain's global operations using Symbiont's Assembly blockchain platform. GrainChain, which operates in Texas, Mexico, and Honduras, plans to expand to several new countries in 2020. The partnership aims to improve platform performance and privacy features.PR NewswireGrainChain Plans Global Expansion Using Symbiont's Enterprise Blockchain PlatformGrainChain, a blockchain platform serving the agricultural ecosystem, announced plans to expand globally by migrating its operations from Hyperledger Fabric to Symbiont's enterprise blockchain platform Assembly, citing the need for better scalability and privacy features to support its growth. The company, which currently operates in Texas, Honduras, and Mexico, recently closed an $8.2 million funding round led by Medici Ventures, the blockchain subsidiary of Overstock.com (NASDAQ:OSTK). Medici Ventures holds ownership stakes in both GrainChain and Symbiont, positioning the move as a strategic alignment of purpose-driven blockchain companies targeting agricultural supply chain inefficiencies worldwide.